Imaging the Effects of R-CHOP and other Anthracycline containing Chemotherapy on Cognitive Function in Patients with high-grade lymphoma
Conditions
Lymphoma
What is the purpose of this trial?
The study provides a critical opportunity to address the effects of R-CHOP and other anthracycline containing chemotherapy on brain and cognitive function as measured by fMRI. The results could serve as a benchmark to enhance the understanding of the central nervous system effects of R-CHOP and other anthracycline containing chemotherapy and the impact on quality of life of lymphoma survivors.
Participation Guidelines
- Age:
- 18 and older
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- The William O Seery Foundation
- Dates:
- October 2010
- Last Updated:
- Study HIC#:
- 1009007419
Clinicaltrials.gov ID: Yale5915142
